Effect of bevacizumab in first-line chemotherapy on progression-free survival in advanced ovarian clear cell carcinoma.

被引：0
|
作者：
Tate, Shinichi [1 ]
Nishikimi, Kyoko [1 ]
Matsuoka, Ayumu [1 ]
Shozu, Makio [1 ]
机构：
[1] Chiba Univ, Grad Sch Med, Dept Reprod Med, Chiba, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18086
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Bevacizumab in First-Line Chemotherapy Improves Progression-Free Survival for Advanced Ovarian Clear Cell Carcinoma
    Tate, Shinichi
    Nishikimi, Kyoko
    Matsuoka, Ayumu
    Otsuka, Satoyo
    Shiko, Yuki
    Ozawa, Yoshihito
    Kawasaki, Yohei
    Shozu, Makio
    [J]. CANCERS, 2021, 13 (13)
  • [2] Bevacizumab as first-line therapy in metastatic renal cell carcinoma. Progression-free survival for 3 years
    Pichler, R.
    Horninger, W.
    Aigner, F.
    Heidegger, I.
    [J]. UROLOGE, 2016, 55 (03): : 381 - 385
  • [3] Bevacizumab in first-line chemotherapy to improve the survival outcome for advanced ovarian clear cell carcinoma: A multicenter, retrospective analysis.
    Seki, Toshiyuki
    Tate, Shinichi
    Nishikimi, Kyoko
    Unno, Yoichi
    Itoi, Mizue
    Ikeda, Sadatomo
    Yoshikawa, Nobuhisa
    Akashi, Hidehiko
    Suzuki, Eitaro
    Tanaka, Naotake
    Hirakawa, Takashi
    Kajiyama, Hiroaki
    Takano, Hirokuni
    Yoshihara, Kosuke
    Okamoto, Aikou
    Shozu, Makio
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [4] Progression-free survival as a surrogate for overall survival in first-line chemotherapy for advanced pancreatic cancer
    Hamada, Tsuyoshi
    Nakai, Yousuke
    Isayama, Hiroyuki
    Yasunaga, Hideo
    Matsui, Hiroki
    Takahara, Naminatsu
    Mizuno, Suguru
    Kogure, Hirofumi
    Matsubara, Saburo
    Yamamoto, Natsuyo
    Tada, Minoru
    Koike, Kazuhiko
    [J]. EUROPEAN JOURNAL OF CANCER, 2016, 65 : 11 - 20
  • [5] First-Line Maintenance With Erlotinib/Bevacizumab Improves Progression-Free Survival in Advanced Lung Cancer
    不详
    [J]. ONCOLOGY-NEW YORK, 2009, 23 (02): : 182 - +
  • [6] PROGRESSION-FREE SURVIVAL AND POSTPROGRESSION SURVIVAL IN PATIENTS WITH ADVANCED GASTRIC CANCER TREATED WITH FIRST-LINE CHEMOTHERAPY
    Shitara, K.
    Matsuo, K.
    Muro, K.
    Ohtsu, A.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 232 - 232
  • [7] Progression-free survival and post-progression survival in patients with advanced gastric cancer treated with first-line chemotherapy
    Shitara, Kohei
    Matsuo, Keitaro
    Muro, Kei
    Doi, Toshihiko
    Ohtsu, Atsushi
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2013, 139 (08) : 1383 - 1389
  • [8] Progression-free survival and post-progression survival in patients with advanced gastric cancer treated with first-line chemotherapy
    Kohei Shitara
    Keitaro Matsuo
    Kei Muro
    Toshihiko Doi
    Atsushi Ohtsu
    [J]. Journal of Cancer Research and Clinical Oncology, 2013, 139 : 1383 - 1389
  • [9] Correlation of progression-free and post-progression survival with overall survival in phase III trials of first-line chemotherapy for advanced epithelial ovarian cancer
    Shimokawa, M.
    Ohki, M.
    Kaku, T.
    [J]. EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2015, 36 (04) : 370 - 375
  • [10] CORRELATION OF PROGRESSION-FREE AND POST-PROGRESSION SURVIVAL WITH OVERALL SURVIVAL IN PHASE III TRIALS OF FIRST-LINE CHEMOTHERAPY FOR ADVANCED EPITHELIAL OVARIAN CANCER
    Shimokawa, M.
    Ohki, M.
    Kaku, T.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 393 - 393
12345